🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.

“The shining star of our family has dimmed his light for us in the present world,” his relatives confirmed. “After a lengthy and courageous battle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his pioneering neo-soul sound and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The album reached No. 4 on the R&B charts, earned platinum status soon after, and earned several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his music career into the limelight. The record debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The personal depiction showed the singer, famously stripped down to his waist, singing directly into the camera.

D’Angelo retreated from the spotlight after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious car crash that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with a further No. 1 debut on the soul music rankings and a award for Top R&B Record.

Again, in his own enigmatic way, D’Angelo made only a few public outings in the subsequent period.

The musician was scheduled as a top act for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the months before his passing, he had apparently been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent types of the disease, on a gifted artist whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his family, but we are forever thankful for the legacy of extraordinarily moving music he has left us,” his family expressed.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a small organ that generates insulin and is vital in digestion, among additional roles. The size and location of the pancreas in the body make it more difficult to identify cancer.

Although this cancer makes up only approximately three percent of malignancy cases each year in the U.S., it is responsible for 7% of malignancy fatalities.

Nearly seventy thousand people will be found to have this condition and roughly fifty-two thousand will die of the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have limited and ineffective therapies, and a smaller window to make a significant difference on the lives of people,” noted a medical oncologist.

Because pancreatic cancer rarely causes initial signs, it’s often identified only once the disease is late-stage. Even when a individual has symptoms they are usually vague and may be mistaken for a number of everyday ailments.

“As of yet, there is no effective method to identify pancreatic cancer in the early stages, apart from listening to your body and speaking with your doctor if there are unfamiliar signs,” explained a medical director.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become increasingly prevalent among younger people.

“This disease identified before the age of 50 is considered uncommon, yet concerningly, clinicians are beginning to see a growing number of younger patients suffering from this condition,” said a specialist.

Genetic Background Affects Disease Probability

In the absence of effective screening tools for pancreatic cancer, experts emphasized the importance of understanding your family’s cancer history. Certain contributing elements, such as tobacco use and excess weight also play a role in the development of this disease.

African Americans have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have inoperable cancer.

“The initial action toward reducing one’s risk of this condition is understanding personal risk factors. People should examine their family history, hereditary factors, and health issues, such as blood sugar disease, long-term pancreas inflammation, or obesity that may increase their vulnerability,” said a specialist.

Inherited genetic elements are linked to as much as ten percent of all pancreatic cancer instances. If someone in your household has had this disease, you may want to consider DNA analysis.

“For individuals with a relative’s background of this condition or those having high risk genetic mutations, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect early changes in the organ,” he explained.

For those looking to reduce their risk, habit adjustments may make a difference. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Excessive alcohol consumption is associated with pancreatitis, a contributing element for this malignancy, so reducing or abstaining from drinks may assist lower your chance.

Managing your weight or shedding pounds may also aid reduce your risk. People with excess weight are 20% more likely to get pancreatic cancer. Pancreatic cancer also occurs more often in those with diabetes, and reducing weight can also lower the risk of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and more recent mixed drug treatments. There are emerging targeted therapies that already are making an impact,” said a specialist.

For numerous people, however, education about this uncommon but {dev